vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and MOBIX LABS, INC (MOBX). Click either name above to swap in a different company.
MOBIX LABS, INC is the larger business by last-quarter revenue ($1.9M vs $1.1M, roughly 1.6× Insight Molecular Diagnostics Inc.). MOBIX LABS, INC runs the higher net margin — -540.0% vs -2015.4%, a 1475.4% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -40.8%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 28.0%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IMDX vs MOBX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $1.9M |
| Net Profit | $-23.0M | $-10.1M |
| Gross Margin | 42.5% | 31.0% |
| Operating Margin | -2057.5% | -471.1% |
| Net Margin | -2015.4% | -540.0% |
| Revenue YoY | -23.4% | -40.8% |
| Net Profit YoY | 31.5% | 49.0% |
| EPS (diluted) | $-0.75 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | $1.9M | ||
| Q3 25 | $260.0K | $1.9M | ||
| Q2 25 | $518.0K | $2.4M | ||
| Q1 25 | $2.1M | $2.5M | ||
| Q4 24 | $1.5M | $3.2M | ||
| Q3 24 | $115.0K | $3.0M | ||
| Q2 24 | $104.0K | $2.1M | ||
| Q1 24 | $176.0K | $1.1M |
| Q4 25 | $-23.0M | $-10.1M | ||
| Q3 25 | $-10.9M | $-15.7M | ||
| Q2 25 | $-9.7M | $-8.3M | ||
| Q1 25 | $-6.7M | $-2.3M | ||
| Q4 24 | $-33.5M | $-19.8M | ||
| Q3 24 | $-13.5M | $-11.5M | ||
| Q2 24 | $-4.5M | $-7.7M | ||
| Q1 24 | $-9.1M | $-1.8M |
| Q4 25 | 42.5% | 31.0% | ||
| Q3 25 | 53.5% | 50.5% | ||
| Q2 25 | 67.6% | 57.4% | ||
| Q1 25 | 62.0% | 40.6% | ||
| Q4 24 | 40.0% | 53.2% | ||
| Q3 24 | 43.5% | 56.6% | ||
| Q2 24 | 48.1% | 35.5% | ||
| Q1 24 | 25.6% | 16.9% |
| Q4 25 | -2057.5% | -471.1% | ||
| Q3 25 | -4249.2% | -834.9% | ||
| Q2 25 | -1900.0% | -343.4% | ||
| Q1 25 | -318.0% | -311.7% | ||
| Q4 24 | -2262.9% | -461.7% | ||
| Q3 24 | -11752.2% | -378.0% | ||
| Q2 24 | -4453.8% | -454.2% | ||
| Q1 24 | -5265.3% | -747.8% |
| Q4 25 | -2015.4% | -540.0% | ||
| Q3 25 | -4174.6% | -835.8% | ||
| Q2 25 | -1880.7% | -352.0% | ||
| Q1 25 | -312.0% | -91.2% | ||
| Q4 24 | -2255.1% | -626.0% | ||
| Q3 24 | -11733.0% | -390.6% | ||
| Q2 24 | -4355.8% | -373.1% | ||
| Q1 24 | -5186.9% | -153.1% |
| Q4 25 | $-0.75 | $-0.16 | ||
| Q3 25 | $-0.34 | $-0.26 | ||
| Q2 25 | $-0.30 | $-0.17 | ||
| Q1 25 | $-0.26 | $-0.06 | ||
| Q4 24 | $-2.19 | $-0.52 | ||
| Q3 24 | $-0.98 | $-0.33 | ||
| Q2 24 | $-0.36 | $-0.25 | ||
| Q1 24 | $-1.13 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | — |
| Total DebtLower is stronger | — | $6.3M |
| Stockholders' EquityBook value | $-31.5M | $4.7M |
| Total Assets | $25.8M | $32.7M |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | — | $6.3M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | $-31.5M | $4.7M | ||
| Q3 25 | $-9.2M | $-336.0K | ||
| Q2 25 | $1.1M | $425.0K | ||
| Q1 25 | $10.2M | $342.0K | ||
| Q4 24 | $-12.3M | $-3.0M | ||
| Q3 24 | $9.7M | $5.5M | ||
| Q2 24 | $22.7M | $8.5M | ||
| Q1 24 | $11.6M | $4.2M |
| Q4 25 | $25.8M | $32.7M | ||
| Q3 25 | $43.9M | $37.1M | ||
| Q2 25 | $50.5M | $34.6M | ||
| Q1 25 | $60.4M | $36.5M | ||
| Q4 24 | $35.1M | $37.3M | ||
| Q3 24 | $70.2M | $39.1M | ||
| Q2 24 | $74.7M | $41.3M | ||
| Q1 24 | $71.0M | $29.5M |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.26× | ||
| Q1 25 | — | 13.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.62× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-4.8M |
| Free Cash FlowOCF − Capex | $-7.0M | — |
| FCF MarginFCF / Revenue | -616.7% | — |
| Capex IntensityCapex / Revenue | 129.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | $-4.8M | ||
| Q3 25 | $-4.5M | $-4.5M | ||
| Q2 25 | $-6.3M | $-4.1M | ||
| Q1 25 | $-5.9M | $-586.0K | ||
| Q4 24 | $-5.4M | $-930.0K | ||
| Q3 24 | $-5.5M | $-3.6M | ||
| Q2 24 | $-6.0M | $-3.1M | ||
| Q1 24 | $-3.8M | $-8.1M |
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | $-4.6M | ||
| Q2 24 | $-6.2M | $-3.1M | ||
| Q1 24 | $-3.9M | $-9.1M |
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | -157.1% | ||
| Q2 24 | -5931.7% | -151.8% | ||
| Q1 24 | -2189.8% | -794.1% |
| Q4 25 | 129.9% | — | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | 34.5% | ||
| Q2 24 | 183.7% | 2.2% | ||
| Q1 24 | 13.6% | 87.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMDX
Segment breakdown not available.
MOBX
| US | $1.7M | 92% |
| Other | $155.0K | 8% |
